Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.9B | 8.5B | 9.5B | 8.7B |
Cost of revenue | 5.5B | 5.9B | 6.9B | 6.0B |
Gross profit | 2.4B | 2.6B | 2.7B | 2.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 179M | 187M | 210M | 199M |
Other operating expenses | 617M | 625M | 613M | 645M |
Operating income | 287M | 428M | 565M | 455M |
Non operating interest income | ||||
Income | 92M | -135M | 79M | 59M |
Expense | 208M | -64M | 187M | 172M |
Other income expense | — | — | — | — |
Pretax income | 183M | 349M | 487M | 344M |
Tax provision | 64M | 120M | 129M | 88M |
Net income | 118M | 229M | 357M | 257M |
Basic EPS | 4.9 | — | 14.7 | 10.5 |
Diluted EPS | 4.9 | — | 14.6 | 10.5 |
Basic average shares | 23.0M | — | 23.2M | 23.4M |
Diluted average shares | 23.0M | — | 23.2M | 23.4M |
EBITDA | 668M | 561M | 942M | 798M |
Net income from continuing op. | 565M | 709M | 834M | 737M |
Minority interests | -5M | -9M | -17M | -11M |
Preferred stock dividends | 0 | 0 | 0 | 0 |